Initial experience with a novel EUS-guided core biopsy needle (SharkCore): results of a large North American multicenter study.

Endosc Int Open · 2016 · PMC5025313 · PMID 27652304

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

In the current study, we demonstrated a strong trend towards a higher pathologic yield compared to cytologic yield (87 % vs 68 %, NS) for EUS-TA of SET, with a median number of 2 needle passes required for core biopsy.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.